Discontinuation of naproxen suspension [6]

Australian Prescriber

Volumn 25, Issue 5, 2002, Pages 106-107

  Gazarian, Madlen ^a   Murray, Kevin ^b,c   Roberton, Don ^d,e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Australian and New Zealand Paediatric Rheumatology Group   (New Zealand)

^c PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^d ROYAL AUSTRALASIAN COLLEGE OF PHYSICIANS   (Australia)

^e WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; FLAVORING AGENT; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB;

AUSTRALIA; CHILD CARE; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; HUMAN; LETTER; STOMACH DISEASE; SUSPENSION;

EID: 0036392144     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)